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Methods and Results Subjects in the Framingham Heart Study were routinely evaluated with M-mode echocardiography; 1924 1.66) , and sum of septal and left trial fibrillation has been shown to be associated with increased risk for cardiovascular disease 1 k morbidity1'2 and mortality.3'4 Nonrheumatic atrial fibrillation carries a nearly fivefold increased risk for stroke compared with normal sinus rhythm.5 Moreover, because of the sharp rise in atrial fibrillation incidence with advancing age, the proportion of strokes occurring in the setting of this dysrhythmia assumes greater magnitude in the elderly.5 Recent trials have demonstrated the efficacy of prophylactic anticoagulation for reducing the incidence of stroke in patients with nonrheumatic atrial fibrillation. [6] [7] [8] [9] Identification of factors predisposing to atrial fibrillation may have implications for its prevention and may facilitate the detection of subjects most susceptible to atrial fibrillation and its sequelae. Although previous case-control studies have reported an increase in prevalence of left atrial enlargement in patients with atrial fibrillation,10-12 to the best of our knowledge, no prior ventricular posterior wall thicknesses (HR per 4-mm increment, 1.28; 95% CI, 1.03 to 1.60) as independent echocardiographic predictors of atrial fibrillation. For each of the echocardiographic predictors, risk increased progressively over successive quartiles. Moreover, risk increased markedly when highest-risk-quartile measurements for these features were present in combination; the cumulative 8-year age-adjusted atrial fibrillation rates were 7.3% and 17.0%, respectively, when one and two or more highest-risk-quartile features were present, compared with 3.7% when none was present.
Conclusions 
Methods
The study sample consisted of original subjects from the Framingham Heart Study who have been followed with biennial examinations since 1948 and who were between 30 and 62 years of age at study inception. Details concerning the methods of data collection and cohort surveillance are described elsewhere.1314 Between 1979 and 1981, M-mode echocardiograms were performed on surviving subjects who participated in the 16th biennial examination (hereafter referred to as the index examination). At this index examination, routine histories, physical examinations, and laboratory evaluations were obtained. Surveillance for development of cardiovascular disease included routine procurement of outside physician reports and hospital records. Every suspected cardiovascular event was reviewed by a committee of three physicians who examined all available evidence. two measurements by physicians. Subjects were considered hypertensive if they had high blood pressure or were receiving drug treatment for hypertension at the index examination. The criteria for diabetes included a random nonfasting blood glucose level >11.11 mmol/L (200 mg/cdL) and the use of insulin or an oral hypoglycemic agent. Valvular heart disease was considered present if a grade 3/6 or higher systolic murmur or any diastolic murmur was detected on physical examination. Coronary heart disease included angina pectoris, coronary insufficiency (unstable angina with documented ECG changes), or myocardial infarction. Criteria for coronary heart disease and congestive heart failure have been described previously.'-Subjects were excluded from this study for either of the following conditions: (1) a history of atrial fibrillation at or before the index examination or (2) a technically inadequate or unavailable echocardiogram at the index examination. Subjects with echocardiographically determined mitral stenosis were excluded from eligibility in accordance with other investigations of nonrheumatic atrial fibrillation. 7, 8 The initial assessment of atrial fibrillation was made by the examining physician on interpretation of a 12-lead ECG obtained at each routine Framingham Heart Study examination or by a review committee in the case of ECGs obtained from hospitalizations or office visits to outside physicians. All tracings were subsequently reviewed and verified by a cardiologist (D.L. or E.J.B.).
Echocardiographic Methods
Standard M-mode echocardiograms were routinely performed at the index examination. A 2.25-MHz, 1.25-cmdiameter, unfocused Aerotech transducer (KB Aerotech, Lewiston, Pa) and a Hoffrel 201 ultrasound receiver (Hoffrel Instruments, Norwalk, Conn) interfaced with a Honeywell 1856 strip chart recorder (Honeywell, Minneapolis, Minn) were used.
Left atrial size was determined in accordance with American Society of Echocardiography recommendations using a leading edge-to-leading edge convention to measure the maximal distance between the posterior aortic root wall and the posterior left atrial wall at end systole. 16 Left ventricular wall thicknesses and internal dimensions were measured according to the methods described by Devereux and Reichek'7 (Penn convention). The modified cubed formula, which uses end-diastolic left ventricular measurements made in accordance with the Penn convention, was used to calculate left ventricular mass.17 Left ventricular mass (in grams) is equal to 1.04 [(left ventricular end-diastolic dimension plus septal wall thickness plus left ventricular posterior wall thickness)3 minus (left ventricular end-diastolic dimension)3] minus 13.6. Left ventricular mass was standardized for body size by dividing left ventricular mass by height in meters. 18 Mitral annular calcification was defined as the presence of a cluster of dense high-intensity echoes between the posterior left ventricular wall and the posterior mitral leaflet.19 Percent left ventricular fractional shortening was defined as 100 times the difference between the end-diastolic and end-systolic left ventricular internal dimensions divided by the end-diastolic left ventricular internal dimension. Mitral stenosis was assessed on the basis of decreased diastolic E-F closing slope, decreased mitral leaflet excursion, thickened mitral leaflets, and anterior motion of the posterior mitral leaflet.
Statistical Analysis
Cox proportional hazards regression models20 using the SAS procedure PHREG21 were used to study the relation between echocardiographic variables and the incidence of atrial fibrillation. In this model, subjects contributed to the follow-up until they (1) developed atrial fibrillation, (2) last attended a routine biennial examination, or (3) died of any cause during the designated follow-up interval. All regression models were stratified by age and sex. Echocardiographic variables evaluated were left atrial size, left ventricular internal dimensions (end-diastolic and end-systolic), ventricular septal and left ventricular posterior wall thicknesses, left ventricular mass/ height, left ventricular fractional shortening, and mitral annular calcification. Both age-and sex-adjusted and age-, sex-, and clinical covariate-adjusted analyses were used to evaluate the impact of each echocardiographic variable on the risk of atrial fibrillation. The clinical covariates included in the model were coronary heart disease, congestive heart failure, hypertension (elevated blood pressure or use of antihypertensive medication), valvular heart disease, and diabetes. These clinical covariates were chosen because of their potential relation to either atrial fibrillation risk or echocardiographic findings.
Multivariable (age-, sex-, and clinical covariate-adjusted) proportional-hazards forward stepwise analysis was used to determine which echocardiographic variables independently contributed to the prediction of atrial fibrillation risk. In this analysis, echocardiographic variables were assessed both one at a time and simultaneously. The criteria for entry into the model and removal from the model were significance levels <0.10 and >0.05, respectively. The variable "sum of (left ventricular) wall thickness" was created and used in the stepwise analysis because the ventricular septal wall thickness and left ventricular posterior wall thickness variables were highly correlated with each other (r=.88).
Hazard ratios (HR) and 95% confidence intervals (95% CI) for atrial fibrillation incidence were calculated from the proportional-hazards analyses. For continuous variables, increments -1 SD were chosen. A two-sided P value <.05 was required to fulfill statistical significance.
The echocardiographic variables that remained significantly related to atrial fibrillation risk in the stepwise analysis were evaluated subsequently by quartile in an age-and sex-adjusted proportional-hazards model. In a further analysis, subjects were stratified according to the presence of highest-riskquartile values for the echocardiographic predictors identified in the stepwise model (fourth quartile for left atrial size and left ventricular wall thickness; first quartile for left ventricular fractional shortening). Cumulative atrial fibrillation incidence rates, calculated according to the presence of 0, 1, or 2 or more highest-risk-quartile values, were derived from age-adjusted Kaplan-Meier analysis.
Results

Study Sample
Of the 2351 subjects evaluated at the index examination, 1924 subjects (82%) were eligible for analysis after exclusions were made for prevalent atrial fibrillation, unavailable or technically inadequate echocardiograms, and mitral stenosis ( Table 1 ). The eligible subjects ranged in age from 59 to 90 years; 61% were women. Information on baseline clinical characteristics was complete in >99% (1911/1924) of eligible subjects. These baseline characteristics are provided in Table 2 . Subjects who developed atrial fibrillation during follow-up were older and more commonly had clinically apparent coronary heart disease and valvular heart disease.
Among eligible subjects, availability of echocardiographic data was greatest for left atrial dimension (100%) but was lower for left ventricular internal dimensions and wall thicknesses (67% to 69%) and mitral annular calcification (56%). Echocardiographic features of study subjects according to incident atrial fibrillation status are presented in Table 3 . 
Analysis of Echocardiographic Variables
The results of the age-and sex-adjusted proportionalhazards regression analyses are summarized in Table 4 . In the analyses, the relation of each echocardiographic variable to atrial fibrillation risk was statistically significant. After additional adjustment for coronary heart disease, valvular heart disease, hypertension, diabetes, and congestive heart failure, each echocardiographic variable remained significantly associated with risk of atrial fibrillation, with the exception of left ventricular end-diastolic dimension ( Table 4) .
The findings from the multivariable stepwise analysis are summarized in Table 5 subjects with and without hypertension, ischemic heart disease, or rheumatic heart disease and in a more recent study by Keren et a112 of 68 subjects with mitral stenosis and 34 subjects with structurally normal mitral valves, similar stepwise increases in left atrial dimension according to the presence of sinus rhythm, transient atrial fibrillation, and chronic atrial fibrillation were also observed.
More recently, a prospective study with limited follow-up (mean, 20 months) of a small cohort (n=20) with preexisting left atrial enlargement (245 mm) did not demonstrate an increased susceptibility to atrial fibrillation. 25 Although study design limited the ability of previous studies to provide definitive proof that left atrial enlargement precedes the development of atrial fibrillation, recent follow-up studies have provided evidence that left atrial size increases after the onset of atrial fibrillation.26227
The independent contributions of left ventricular wall thickness and left ventricular fractional shortening to risk of atrial fibrillation have not been documented previously. Although left atrial size was correlated with left ventricular wall thickness (r=.38 to .40) and to a lesser extent with fractional shortening (r= -.10), both left ventricular wall thickness and fractional shortening remained predictive of atrial fibrillation risk when considered simultaneously with left atrial dimension. Increased left ventricular wall thickness and/or impaired fractional shortening frequently accompany clinical conditions that are associated with increased atrial fibrillation incidence, such as hypertrophic,28 infiltrative,29 and ischemic30 cardiomyopathies.
Among the 1292 subjects with echocardiographic data available for all three predictors, the presence of multiple highest-risk-quartile measurements resulted in additive risk for atrial fibrillation. Subjects with at least two highest-risk-quartile measurements for left atrial size, left ventricular wall thickness, and left ventricular fractional shortening (19% of the study sample) were at greatest risk of developing atrial fibrillation (17% cumulative incidence over a period of 8 years). Conversely, subjects without highest-risk-quartile measurements for any of the three echocardiographic predictors (45% of the study sample) were at lowest risk for atrial fibrillation incidence (3.7% cumulative incidence over the 8-year follow-up interval 
Clinical Implications
In this elderly, population-based cohort, subjects with increased left atrial size, increased left ventricular wall thicknesses, or decreased left ventricular fractional shortening were at significantly increased risk for the development of nonrheumatic atrial fibrillation. In addition to providing a quantitative assessment of risk, the present study clarifies the roles of several cardiac structural and functional characteristics in relation to susceptibility to atrial fibrillation. The identification of cardiac structural and functional precursors of atrial fibrillation may enhance our understanding of mechanisms responsible for this dysrhythmia.
Perhaps the best method for reducing the adverse complications associated with atrial fibrillation is through prevention of the development of atrial fibrillation itself. Recent studies suggest that increased risk of thromboembolism exists in subjects with atrial fibrillation who have left atrial dilatation37'38 or decreased left ventricular systolic function.38 As such, subjects at greatest risk for the development of nonrheumatic atrial fibrillation may be at greatest risk for thromboembolic complications. The commonality of risk factors both for the development of atrial fibrillation and its complications suggests a role for preventive strategies. However, delineation of such preventive measures and their utility await additional investigation.
